SMTL ID : 2fz8.1

Human Aldose reductase complexed with inhibitor zopolrestat at 1.48 A(1 day soaking).

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.48 Å

Oligo State

monomer

Ligands

1 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 33 residues within 4Å: Chain A: G.19, T.20, W.21, K.22, D.44, Y.49, K.78, H.111, W.112, S.160, N.161, Q.184, Y.210, S.211, P.212, L.213, G.214, S.215, P.216, D.217, L.229, A.246, I.261, P.262, K.263, S.264, V.265, T.266, R.269, E.272, N.273, C.299 Ligands: ZST.2 28 PLIP interactions: 28 interactions with chain A Hydrophobic interactions: A:W.21 Hydrogen bonds: A:T.20, A:W.21, A:D.44, A:S.160, A:N.161, A:Q.184, A:S.211, A:L.213, A:S.215, A:S.215, A:D.217, A:D.217, A:K.263, A:S.264, A:V.265, A:T.266, A:T.266, A:E.272, A:N.273 Water bridges: A:R.269, A:R.269 Salt bridges: A:K.22, A:K.22, A:K.263, A:R.269 pi-Stacking: A:Y.210 pi-Cation interactions: A:R.269

1 x ZST: 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID(Non-covalent)

ZST.2: 16 residues within 4Å: Chain A: W.21, Y.49, W.80, H.111, W.112, T.114, F.116, F.123, W.220, C.299, A.300, L.301, C.304, Y.310, P.311 Ligands: NAP.1 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:W.21, A:W.21, A:Y.49, A:W.112, A:F.116, A:F.123 Hydrogen bonds: A:Y.49, A:Y.49, A:L.301 Salt bridges: A:H.111 pi-Stacking: A:W.112, A:W.112, A:W.112 Halogen bonds: A:C.304

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Steuber, H. et al., Expect the Unexpected or Caveat for Drug Designers: Multiple Structure Determinations Using Aldose Reductase Crystals Treated under Varying Soaking and Co-crystallisation Conditions. J.Mol.Biol. (2006)

Release Date

2006-10-03

Peptides

aldose reductase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

aldose reductase

Related Entries With Identical Sequence